Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care (ASPIRE)
Primary Purpose
Heavy Drinking, Driving Under the Influence, Riding With Driver Under the Influence
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Computer-facilitated Screening and Brief Intervention
Sponsored by

About this trial
This is an interventional treatment trial for Heavy Drinking
Eligibility Criteria
Inclusion Criteria:
- Ages 14-17
- Presenting for well-visit with participating clinician
- Reports any past 12 month alcohol use
- If no past-12-month alcohol use, reports riding with a driver under the influence in the past 12 months
- Has own cell phone and is willing to share cell phone number before their scheduled visit
- Completes required pre-visit activity/activities before well visit
Exclusion Criteria:
- Youth in foster care
- Unable to read and communicate in English
- College students at time of recruitment
- Unable to complete follow-ups
- Currently receiving treatment from specialty clinician(s) for a substance use concern
- Deemed by their clinician to be inappropriate for study participation due to neurodevelopmental delays or medical/emotional concerns
Sites / Locations
- American Academy of PediatricsRecruiting
- Boston Children's HospitalRecruiting
- Children's Hospital of PhiladelphiaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual Care
Computer-facilitated screening and brief intervention
Arm Description
Clinicians randomized to this arm will not receive training in delivery of cSBI until study completion, and their participating patients will receive usual care.
Clinicians randomized to this arm will receive training in delivery of cSBI and their participating patients will then receive the experimental intervention.
Outcomes
Primary Outcome Measures
Any heavy episodic drinking day during past 3 months
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Any heavy episodic drinking day during past 3 months
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Any heavy episodic drinking day during past 3 months
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Any heavy episodic drinking day during past 3 months
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Secondary Outcome Measures
Any riding/driving risk
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Any riding/driving risk
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Any riding/driving risk
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Any riding/driving risk
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Full Information
NCT ID
NCT04450966
First Posted
June 25, 2020
Last Updated
April 14, 2023
Sponsor
Boston Children's Hospital
Collaborators
American Academy of Pediatrics, Children's Hospital of Philadelphia
1. Study Identification
Unique Protocol Identification Number
NCT04450966
Brief Title
Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care
Acronym
ASPIRE
Official Title
Computer-facilitated Screening and Brief Intervention (cSBI) in Pediatric Primary Care to Reduce Underage Drinking: a Large, Multi-site Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 10, 2023 (Actual)
Primary Completion Date
March 31, 2025 (Anticipated)
Study Completion Date
October 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital
Collaborators
American Academy of Pediatrics, Children's Hospital of Philadelphia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Our goal is to conduct a large multi-site randomized controlled trial (RCT) of a promising computer-facilitated Screening and clinician Brief Intervention (cSBI) system designed for delivery by pediatric primary care clinicians and aimed at reducing unhealthy alcohol use and related riding/driving safety risk among adolescent patients. Our setting will be the American Academy of Pediatrics' (AAP) Pediatric Research in Office Settings (PROS) national primary care research network, with >600 U.S. primary care practices having participated in recent studies. This trial addresses the evidence gap identified in the latest U.S. Preventive Services Task Force review of alcohol screening and brief counseling interventions among adolescents, and, if shown effective, the cSBI system could be widely disseminated via AAP's existing education, teaching, and advocacy platforms to its 67,000 pediatrician members, thereby greatly increasing the potential for population-level impact of alcohol screening and brief intervention for U.S. adolescents.
Detailed Description
Alcohol use disorders frequently have a pediatric origin. Pediatric primary care offices, where the majority of adolescents receive health care, are a promising venue for early identification and intervention through universal screening and brief counseling. However, while the U.S. Preventive Services Task Force recommends primary care-based alcohol screening and brief intervention for adults, it found insufficient evidence to recommend it for adolescents.
The goal of the proposed study is to address this evidence gap by testing the effectiveness of a promising computer-facilitated Screening and Brief Intervention (cSBI) system for delivery by pediatric primary care clinicians to adolescents at well-visits. This cluster-randomized controlled trial will be conducted in the American Academy of Pediatrics' (AAP) Pediatric Research in Office Settings (PROS) national primary care practice-based research network. PROS has demonstrated success in >30 years of practice-based research, with >600 practices participating in recent studies. Drawing on more than 15 years of our prior research on adolescent alcohol screening and brief counseling in primary care offices, the cSBI system was developed to provide a time-efficient and feasible way for pediatric practices to improve both the frequency and quality of alcohol screening and counseling. cSBI includes: 1) computer self-administered screening that adolescents complete prior to seeing their clinician, 2) 10 interactive psychoeducational pages for the adolescent on substance use health risks, 3) a Clinician Report Form with screen results and prompts that clinicians use to provide motivational interviewing-based individualized counseling, and 4) clinician training materials and protocol.
In a New England-based pilot study, we found that, compared to usual care (UC), the cSBI approach: 1) increased patient receipt of alcohol-related counseling during well-visits; 2) improved patients' ratings of the quality of their clinician encounter; and 3) among those who reported past-year use at baseline (n=192), was associated with a 34% lower risk of a heavy episodic drinking episode during 12 months follow-up. cSBI also reduced risk of riding with an impaired driver, a major safety risk associated with alcohol, by 42% among those with prior riding risk.
A larger RCT of this approach, which employs an adequately-powered sample and tests generalizability of effects beyond New England, is needed. We will randomize >30 pediatric primary care clinicians in ~10 practices nationwide to deliver UC or cSBI (1:1) to their eligible and assenting 14- to 17-year-old patients arriving for well-visits. Our aims are to test cSBI's effect on heavy episodic drinking, and on riding with an impaired driver/driving while impaired, during 12 months follow-up among 1,300 adolescents screen-identified as at-risk. We hypothesize that, compared to adolescent patients receiving usual care, those receiving cSBI will have lower rates of reporting heavy episodic drinking and riding with an impaired driver/driving while impaired during the study follow-up period.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heavy Drinking, Driving Under the Influence, Riding With Driver Under the Influence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multi-site cluster-randomized parallel groups trial. >30 pediatric primary care clinicians will be recruited from ~10 practices and will be allocated 1:1 to either deliver usual care or the cSBI intervention to their participating patients ages 14-17 years-old.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
1300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Clinicians randomized to this arm will not receive training in delivery of cSBI until study completion, and their participating patients will receive usual care.
Arm Title
Computer-facilitated screening and brief intervention
Arm Type
Experimental
Arm Description
Clinicians randomized to this arm will receive training in delivery of cSBI and their participating patients will then receive the experimental intervention.
Intervention Type
Behavioral
Intervention Name(s)
Computer-facilitated Screening and Brief Intervention
Other Intervention Name(s)
cSBI
Intervention Description
cSBI includes: 1) computer self-administered screening that adolescents complete prior to seeing their clinician, immediately followed by 2) computer-delivered brief psychoeducation on the health risks of substance use to prime patients for the clinician encounter, and 3) a Clinician Report Form with screen results and prompts that clinicians use to provide motivational interviewing-based individualized counseling during the visit.
Primary Outcome Measure Information:
Title
Any heavy episodic drinking day during past 3 months
Description
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Time Frame
3 months follow-up
Title
Any heavy episodic drinking day during past 3 months
Description
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Time Frame
6 months follow-up
Title
Any heavy episodic drinking day during past 3 months
Description
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Time Frame
9 months follow-up
Title
Any heavy episodic drinking day during past 3 months
Description
Defined using the NIAAA Youth Guide age/gender-specific number of drinks.
Time Frame
12 months follow-up
Secondary Outcome Measure Information:
Title
Any riding/driving risk
Description
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Time Frame
3 months follow-up
Title
Any riding/driving risk
Description
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Time Frame
6 months follow-up
Title
Any riding/driving risk
Description
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Time Frame
9 months follow-up
Title
Any riding/driving risk
Description
Any riding with a driver who had been using alcohol or driving after using alcohol in past 3 months
Time Frame
12 months follow-up
Other Pre-specified Outcome Measures:
Title
Alcohol-related problems or negative consequences experienced since baseline
Description
Score on scale
Time Frame
6 months follow-up
Title
Alcohol-related problems or negative consequences experienced since baseline
Description
Score on scale
Time Frame
12 months follow-up
Title
Past 3 months alcohol use days
Description
Number of days of any alcohol use in past 3 months
Time Frame
3 months follow-up
Title
Past 3 months alcohol use days
Description
Number of days of any alcohol use in past 3 months
Time Frame
6 months follow-up
Title
Past 3 months alcohol use days
Description
Number of days of any alcohol use in past 3 months
Time Frame
9 months follow-up
Title
Past 3 months alcohol use days
Description
Number of days of any alcohol use in past 3 months
Time Frame
12 months follow-up
Title
Past 3 months heavy episodic drinking days
Description
Number of days of heavy episodic drinking in past 3 months
Time Frame
3 months follow-up
Title
Past 3 months heavy episodic drinking days
Description
Number of days of heavy episodic drinking in past 3 months
Time Frame
6 months follow-up
Title
Past 3 months heavy episodic drinking days
Description
Number of days of heavy episodic drinking in past 3 months
Time Frame
9 months follow-up
Title
Past 3 months heavy episodic drinking days
Description
Number of days of heavy episodic drinking in past 3 months
Time Frame
12 months follow-up
Title
Perceived risk of harm
Description
Percent report perceiving moderate/great risk of harm from regular heavy episodic drinking
Time Frame
3 months follow-up
Title
Perceived risk of harm
Description
Percent report perceiving moderate/great risk of harm from regular heavy episodic drinking
Time Frame
6 months follow-up
Title
Perceived risk of harm
Description
Percent report perceiving moderate/great risk of harm from regular heavy episodic drinking
Time Frame
9 months follow-up
Title
Perceived risk of harm
Description
Percent report perceiving moderate/great risk of harm from regular heavy episodic drinking
Time Frame
12 months follow-up
Title
Drinking refusal self-efficacy
Description
Score on Drinking Refusal Self-Efficacy measure
Time Frame
3 months follow-up
Title
Drinking refusal self-efficacy
Description
Score on Drinking Refusal Self-Efficacy measure
Time Frame
6 months follow-up
Title
Drinking refusal self-efficacy
Description
Score on Drinking Refusal Self-Efficacy measure
Time Frame
9 months follow-up
Title
Drinking refusal self-efficacy
Description
Score on Drinking Refusal Self-Efficacy measure
Time Frame
12 months follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Ages 14-17
Presenting for well-visit with participating clinician
Reports any past 12 month alcohol use
If no past-12-month alcohol use, reports riding with a driver under the influence in the past 12 months
Has own cell phone and is willing to share cell phone number before their scheduled visit
Completes required pre-visit activity/activities before well visit
Exclusion Criteria:
Youth in foster care
Unable to read and communicate in English
College students at time of recruitment
Unable to complete follow-ups
Currently receiving treatment from specialty clinician(s) for a substance use concern
Deemed by their clinician to be inappropriate for study participation due to neurodevelopmental delays or medical/emotional concerns
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sion K Harris, PhD
Phone
857-218-4304
Email
sion.harris@childrens.harvard.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Lydia A. Shrier, MD, MPH
Phone
617-355-5133
Email
lydia.shrier@childrens.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sion K Harris, PhD
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
American Academy of Pediatrics
City
Itasca
State/Province
Illinois
ZIP/Postal Code
60143
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alison Torres, MPH
Email
atorres@aap.org
First Name & Middle Initial & Last Name & Degree
Donna L Harris, MA
Email
dlharris@aap.org
First Name & Middle Initial & Last Name & Degree
Alison Torres, MPH
Facility Name
Boston Children's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sion K Harris, PhD
First Name & Middle Initial & Last Name & Degree
Lydia A. Shrier, MD
First Name & Middle Initial & Last Name & Degree
Pamela J. Burke, PhD, RN, FNP
Facility Name
Children's Hospital of Philadelphia
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexander Fiks, MD, MSCE
Email
fiksa@email.chop.edu
First Name & Middle Initial & Last Name & Degree
Alex Fiks, MD
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
We will provide a variable codebook along with the dataset. We will make a de-identified version of the complete and cleaned study dataset available to the AAP's PROS Study Archive at study completion, as well as NIAAA Data Archive (NIAAADA).
IPD Sharing Time Frame
Within 12 months of study completion.
IPD Sharing Access Criteria
We will share the dataset with external investigators when a data use agreement (DUA) is executed between Boston Children's Hospital and the institution of the person making the request. The DUA will specify the requested data elements (each of which must be justified), the specific research question, the timeline for the project and schedule for data destruction.
Learn more about this trial
Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care
We'll reach out to this number within 24 hrs